HIMS - Hims & Hers Health, Inc.
The law firm of [url="]Robbins Geller Rudman and Dowd LLP[/url] announces that purchasers or acquirers of Hims and Hers Health, Inc. (NYSE: HIMS) securities between
SAN DIEGO--(BUSINESS WIRE)---- $HIMS #HIMS--The case alleges Hims & Hers and its top executives made false and/or misleading statements to investors.
New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.
Did you buy HIMS securities between August 4, 2025 and July 29, 2026 ? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What: Securities fraud class action lawsuit filed Class Period: August 4, 2025 through July 29, 2026 Deadline to Seek Lead Plaintiff Status: November 2, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's deceptive and unlawful privacy practices Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options Radnor, Pa.
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the “Class Period”), of the important November 2, 2026 lead plaintiff deadline.
SAN FRANCISCO, Sept. 10, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
New York, New York--(Newsfile Corp. - September 10, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/1/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors of the November 2, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Hims to Contact Him Directly to Discuss Their Options New York, New York--(Newsfile Corp. - September 10, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). [You may also click here for additional information] WHY: Faruqi & Faruqi, LLP, a leading national securities law firm, informs investors of the federal securities class action on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period").
LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc., (“Hims & Hers” or the "Company") (NYSE: HIMS) investors of a class action on behalf of investors that bought securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). Hims & Hers investors have until November 2, 2026 to file a lead plaintiff motion.
NEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company's securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
SAN FRANCISCO, Sept. 9, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
New York, New York--(Newsfile Corp. - September 9, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026 inclusive (the “Class Period”).
SAN DIEGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period").
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
New York, New York--(Newsfile Corp. - September 9, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period").
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the “Class Period”).
NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C.